Morphea, also known as localized scleroderma, is a chronic inflammatory connective tissue
disorder with variable clinical presentations, that affects both adults and children. It is …

Background Morphea (morphoea) is an immune‐mediated disease in which excess
synthesis and deposition of collagen in the skin and underlying connective tissues results in …

Morphea, also known as localized scleroderma (LoS), comprises a set of autoimmune
sclerotic skin diseases. It is characterized by inflammation and limited thickening and …

Morphea and systemic sclerosis are inflammatory, sclerosing disorders. Morphea primarily
affects the dermis and subcutaneous fat, while systemic sclerosis typically involves the skin …

Morphea, or localized scleroderma, is a rare disease of the connective tissue that manifests
itself with localized sclerosis of the skin and, in some cases, with extracutaneous …

Abstract Background Localized scleroderma (LoS) affects both children and adults and is
associated with permanent functional and cosmetic impairment, and reduced quality of life …

Localized scleroderma (LS) is an autoimmune disease with sclerosis of the skin as the main
manifestation. Currently, there is no specific treatment for LS. The effectiveness of ablative …

Die vorliegende aktualisierte S2k‐Leitlinie befasst sich mit der Diagnostik und der Therapie
der zirkumskripten Sklerodermie (ZS). Diese umfasst ein Spektrum sklerotischer …

Introduction The aim of the study is to assess the long-term safety and efficacy of hyaluronic
acid (HA) administration in correction of facial morphea lesions and to review the literature …

Sclerodermatous graft versus host disease (sclGVHD) is a debilitating complication of
hematopoietic stem cell transplant and is characterized by skin thickening and fibrosis that …